New research reveals how hemolytic stress in the aging spleen impairs immune performance and points to strategies for restoring function.
The immune system, so often described as a barometer of biological age, becomes markedly less resilient with time; infections linger, vaccines yield weaker responses and inflammatory disorders become more common. Much of this decline has been attributed to cell-intrinsic changes – genomic wear, metabolic slowdown and a dwindling repertoire of naïve T cells – but new work from the Technion-Israel Institute of Technology suggests the story is more complicated.
Shifting terrain in immune aging
According to the team, the spleen itself undergoes architectural and functional deterioration that creates an inhospitable microenvironment for T cells, driving them toward dysfunction even when the cells are, on paper at least, still youthful.
The authors examined T cells drawn from aged mouse spleens and lymph nodes and observed that splenic T cells displayed more pronounced senescent markers, reduced viability and weaker proliferative capacity. Notably, the same trends emerged when young T cells were transferred into aged spleens, implying that the environment – and not only the cells – was at fault. As the authors note, “exposure to the aged splenic microenvironment exacerbated multiple phenotypes associated with T cell aging [1].”
Longevity.Technology: What’s striking here is not simply that T cells grow weary with age – we knew that – but that the spleen itself becomes a hostile landlord, leaking heme and iron in quantities that would make even the hardiest lymphocyte think twice. This work pushes immunosenescence beyond the usual suspects of thymic involution and repertoire collapse, pointing instead to a microenvironment that forces T cells into an unhelpful bargain: survive the oxidative onslaught by throttling iron uptake or function properly and risk ferroptosis. It is a rather unflattering portrait of the aging spleen, but it also opens a window onto interventions that could be both surprisingly low-tech and surprisingly impactful; heme scavenging, timed iron supplementation and ferroptosis modulation suddenly look less like fringe curiosities and more like practical tools for improving vaccine response and infection resilience in older adults. As ever, translation into humans will be the real test – rodent spleens are not destiny – but the suggestion that a failing organ microenvironment can systemically broadcast dysfunction deserves attention, not least because it hints that rejuvenating immunity may require tidying up the biochemical neighborhood as much as reinvigorating the immune cells themselves.
A hemolytic microenvironment
Further analysis showed that aged spleens accumulate senescent red blood cells, heme and iron deposits; the tissue’s normal recycling machinery has evidently faltered. T cells harvested from these spleens contained significantly higher levels of intracellular heme and were bathed in extracellular heme and bilirubin, both measurable in interstitial fluid [1].
Such exposure proved harmful: young T cells activated in the presence of heme exhibited “reduced viability and proliferation” and upregulated CD39, a marker associated with senescence and dampened effector function. Heme treatment also elevated reactive oxygen species and triggered lipid peroxidation, hallmarks of ferroptotic stress. These findings align with the authors’ assertion that “heme induces ROS… and could lead to cell death by ferroptosis [1].”
Yet aged T cells were not dying en masse. Instead, they had adapted by suppressing iron uptake and reducing the labile iron pool, partly through downregulating IRP2. This strategy limited ferroptosis but came at a metabolic cost: limiting iron restricts T cell activation, which depends on iron for DNA synthesis and proliferation.
Balancing survival and function
Proteomic analysis added another layer, revealing that naïve T cells from aged spleens overexpress proteins linked with oxidative stress, heme detoxification and inflammation. Heme oxygenase-1 and ferritin subunits were particularly elevated, hinting at long-term adaptation to hemolytic stress rather than an acute response. As the authors write, these proteins “remained significantly elevated… even after activation,” suggesting enduring rewiring rather than situational tuning [1].
This adaptive phenotype broadly mirrors what is seen in other stressed or damaged tissues, where cells accept functional compromise to avoid death. In the immune system, however, such compromise is problematic: a T cell that cannot proliferate effectively cannot mount a robust response to infection or vaccination.
Therapeutic possibilities
The study tested whether restoring iron availability could improve function. Supplementation with ferric ammonium citrate or holo-transferrin replenished intracellular iron and enhanced proliferation in aged T cells, reducing the proportion of non-dividing cells. In vaccinated aged mice receiving antigen-specific T cells, iron administration increased the frequency of OVA-specific CD4 T cells and elevated IgG1 antibody titers compared to vaccination alone [1].
These findings prompt consideration of how micronutrient availability – and iron in particular – might shape immune competence later in life. Although chronic iron overload presents its own risks, timed supplementation around vaccination or infection could offer a targeted, practical means of boosting immune performance. The study also hints at potential roles for heme scavengers such as hemopexin or albumin, which, in vitro, protected young T cells from the toxic effects of aged splenic extracts.
An evolving landscape
The notion that an aging organ can project dysfunction into the wider immune system is compelling; it also raises questions about how other tissues might shape systemic aging trajectories. Whether similar microenvironmental damage occurs in human spleens remains to be seen, but the possibility invites closer examination of how organ-level decline shapes healthspan.
